Table 3 Associations between serum IL-17 and CAP severity scores in CAP patients

SMART-COP

0–1

1

–

1

–

3–4

9.16 (3.16, 26.57)

 < 0.01

8.93 (3.00, 26.55)

 < 0.01

5–6

4.39 (1.90, 10.12)

 < 0.01

3.63 (1.53, 8.62)

 < 0.01

7–8

23.50 (6.07, 90.95)

 < 0.01

18.12 (4.50, 72.99)

 < 0.01

APACHE II

 < 4

1

–

1

–

4–6

0.95 (0.36, 2.47)

0.91

0.84 (0.30, 2.37)

0.74

6–10

1.47 (0.60, 3.60)

0.40

1.26 (0.47, 3.39)

0.64

 > 10

5.30 (2.32, 12.09)

 < 0.01

4.03 (1.57, 10.30)

 < 0.01

CRB-65

0

1

–

1

–

1–2

1.74 (0.84, 3.58)

0.14

1.29 (0.57, 2.91)

0.55

 ≥ 3

4.79 (1.83, 12.51)

 < 0.01

3.32 (1.18, 9.35)

0.02

CURB-65

0–1

1

–

1

–

2

3.37(1.58, 7.21)

 < 0.01

2.80 (1.27, 6.18)

0.01

3 ~ 5

5.38 (2.47, 11.75)

 < 0.01

4.11 (1.78, 9.53)

 < 0.01

PSI

I

1

–

1

–

II

1.75 (0.60, 5.15)

0.31

1.50 (0.46, 4.90)

0.50

III

1.75 (0.58, 5.23)

0.32

1.36 (0.38, 3.93)

0.64

IV

3.11 (1.08, 8.96)

0.04

2.40 (0.67, 8.67)

0.18

V

22.00 (5.86, 82.65)

 < 0.01

15.41 (3.34, 70.03)

 < 0.01

CURXO

Mild

1

–

1

–

Severe

5.98 (3.10, 11.53)

 < 0.01

5.01 (2.55, 9.86)

 < 0.01